I-Mab (Hangzhou)

Hangzhou, China · Founded 2019 · Privately Held (backing)

Manufacturer of macromolecular antibody drugs focused on integrated biopharmaceutical research and production. I-Mab (Hangzhou) is based in Hangzhou, China and was founded in 2019. It has raised $154 million.

Last price · $/share

—

Implied valuation

—

Total raised

$154.3M

Last round

—

How much has I-Mab (Hangzhou) raised?

$154.3Macross 0 recorded rounds

Free account

More of I-Mab (Hangzhou) with a free account

·The complete investor list: 23 names
·Watch I-Mab (Hangzhou): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

I-Mab (Hangzhou) investors

23 investors are on record for I-Mab (Hangzhou), including HSG (Hong Kong), CICC Capital, Oriental Fortune Capital and Tailong VC.

For fundraisers

Raising for a company like I-Mab (Hangzhou)?

23 investors have backed I-Mab (Hangzhou).

See all 23 investors →

Frequently asked about I-Mab (Hangzhou)

How much has I-Mab (Hangzhou) raised?: I-Mab (Hangzhou) has raised $154.3M in total across 0 recorded funding rounds.